Introduction: Neurogenic neuroprotection elicited by deep brain stimulation is emerging as a promising approach for treating patients with ischemic brain lesions. In rats, stimulation of the fastigial nucleus, but not dentate nucleus, has been shown to reduce the volume of focal infarction. Protection of neural tissue is a rapid intervention that has a relatively long-lasting effect, rendering fastigial nucleus stimulation (FNS) a potentially valuable method for clinical application. Methods: We review some of the main findings of animal experimental research from a clinical perspective. Results: Although the complete mechanisms of neuroprotection induced by FNS remain unclear, important data has been presented in the last two decades. The acute effect of electrical stimulation of the fastigial nucleus is likely mediated by a prolonged opening of potassium channels, and the sustained effect appears to be linked to inhibition of the apoptotic cascade. Conclusion: A better understanding of the cellular and molecular mechanisms underlying neurogenic neuroprotection by stimulation of deep brain nuclei, with special attention to the fastigial nucleus, can contribute toward improving neurological outcomes in ischemic brain insults.
Introduction
The protection of brain tissue after traumatic or ischemic events poses a current challenge for critical neurological care in medical centers worldwide [1] [2] [3] [4] [5] . The goal of neuroprotection is to preserve viable areas of brain tissue in the event of injury in order to restore performance to levels as close as possible to their original physiological functions. This approach constitutes a way of reestablishing the microenvironment and conditions needed for suffering brain neurons to inhibit intrinsic undesirable programmed processes of cell death. Reduction of cellular metabolism and stimulation of trophic properties in these cells is conducive to achieving a new balance for cellular viability. To this end, many types of pharmacological and physical interventions have been employed in intensive care units [1] [2] [3] [4] [5] [6] [7] [8] [9] . However, real benefits of the current treatments are far from ideal, particularly given the difficulties in inhibiting the inexorable cascade triggered by the initial event and in controlling the complications associated with treatment options [4] .
Neurogenic neuroprotection opens up a new frontier for the preservation of the penumbra area in ischemic brain of humans. For the purposes of this review, the penumbra area has been defined as the risk zone for cellular death that is sensitive to therapeutic procedures ( Figure 1 ) [10] [11] [12] [13] [14] [15] [16] [17] . There are no anatomical markers that clearly map the penumbra region, and its borders may overlap with the adjacent necrosis area. This morphological feature indicates the dynamic cellular and molecular events occurring in the penumbra area that can drive some of its regions toward the necrotic center or render them resistant to secondary neurodegeneration. Nevertheless, a detrimental scenario can be modified by introducing procedures that are able to change the apoptotic cycle of damaged cells.
Robust data shows that electrical stimulation of cerebellar fastigial nucleus (FN) can elicit marked global protection against brain injury in rats submitted to different types of hypoxic, ischemic and excitotoxic injury [18] [19] [20] [21] [22] . Longlasting neuroprotective effects have been evidenced that persisted for up to 10 days after nuclei fastifial nucleus stimulation (FNS) [23] .
Moreover, a 50% reduction in neuronal death has been reported following induced ischemic injury, 3 days after stimulation of FN deep in cerebellum [18] , thus revealing a promising method for controlling secondary neuron degeneration in brain ischemia.
Experimental evidence
The cerebellar nuclei were first recognized by Raymond de Vieussens [24] and called the emboliform, globose and fastigial nuclei by Stilling in 1864 [25] . However, evidence of changes in the control of systemic and encephalic blood flow after stimulation or lesion of cerebellum nuclei dates back to 1969 [26] [27] [28] . These observations led to the notion of a possible effect of FNS on adjacent areas of brain infarct [22] . FNS for 1 hour in rats has been shown to reduce infarction volume by 50% compared to non-stimulated control animals [18, [20] [21] [22] 29] . The region of spared tissue is referred to as the area of penumbra, whose neurons enjoy neuroprotection through inhibition of the secondary neurodegeneration process [19] . Although the effects of experimental FNS have been well established, the mechanisms underlying this neurogenic neuroprotection remain a topic of intense investigation [30] .
Neuronal circuitry
The electrical stimulation of FN influences local neurons as well as the abundant fibers of passage within the nucleus and surrounding area [31] . Stimulation of the rostromedial portion of the cerebellar FN in rat triggers a stimulus-locked elevation of arterial pressure and heart rate [32] [33] [34] [35] . This response, discovered in 1969 by Miura and Reis [28] and Achari and Downman [26] in anesthetized cats, is known as "the fastigial pressor response" (FPR). In contrast, microinjection of excitatory amino acids, which only excite neuronal perikarya, decreases arterial pressure and heart rate [33, 36, 37] . These observations can explain the apparent paradoxical findings seen after indiscriminate FN electrical stimulation.
Nevertheless, the excitation of passage fibers seems to be as essential as the stimulation of intrinsic neurons in evoking neurogenic neuroprotection [18] . Since the effects in the brain appear to be global, the network responsible for this action might consist of widespread brain projections from the nucleus [31] . However, this is not the case for FN, which possesses relatively short projections into the vestibular nucleus, reticular dorsal and paramedian formation, many pontine nuclei including the locus coeruleus, the parabranchial nucleus as well as the centromedial thalamic nucleus and parafascicular complex, substantia nigra and amygdala [28, 30, [38] [39] [40] [41] .
The same neuroprotective response observed after stimulation of the FN was vasoconstrictor, is employed to promote focal and permanent experimental ischemia in brain parenchyma with formation of a necrosis zone and a surrounding penumbra region. One section was stained for OX-42 immunoreactivity (brownish color, a marker for activated microglia/macrophages) and counterstained with cresyl violet (bluish color) for visualization of inter alia neuronal/glial cell nuclei. Adjacent section was stained for glial fibrillary acidic protein (GFAP) immunoreactivity (reddish color, a marker for activated astrocytes). The image layer of astroglial staining with 52% transparency was placed over the microglial macrophage/cresyl violet staining. The internal dots surround the necrosis area (Ne), while the external dots surround the penumbra area (Pe). The panels B and C are the dark field images of the OX-42 and GFAP immunolabelings shown in panel A. Note the presence of small infiltrating cells stained for cresyl violet in the necrosis region, also possessing OX-42 immunolabeling, thus being of macrophage nature (A, B). Few GFAP positive astrocytes are seen in the necrosis region (A, C). In the penumbra area, massive infiltrations of microglia/macrophages and astrocytes coexist with surviving neurons (not shown). The molecular events that take place in the penumbra area trigger neuronal/non neuronal cell death or salvage, leading to the region being incorporated into the necrosis area or undergoing the process of neuroplasticity-induced neurofunctional restoration, respectively. Abbreviations: ET-1, endothelin-1; Par, parietal cortex; cc, corpus callosum; aca, anterior commissure; Pir, piriform cortex; Ne, necrosis area; Pe, penumbra area. Scale bar = 200µm. also evoked by stimulation of the dorsal periaqueductal gray matter (DPAG) area and subthalamic vasodilator area (SVA) [42, 43] . One possibility is that DPAG stimulation-induced conditioned neuroprotection is mediated by intrinsic FN neurons (Figure 2 ). Some studies have revealed that FN efferents, labeled with radioactive amino acids, project into the lateral edge of the PAG in monkeys and dogs [39, 44] , while other authors have shown that caudal FN regions involved in oculomotor systems also have fine fibers that extend into the PAG [45] . Additionally, the PAG also has extensive ascending projections to the midline, intralaminar, and reticular thalamic nuclei, as well as the hypothalamus and basal forebrain [46] [47] [48] [49] . The presence of these projections supports the notion that the DPAG excites the neuroprotective response of SVA, which is independent from the FN [42] . Earlier observations suggest that stimulation of the RVLM might produce some neuroprotective effects (~25%) [29, 53] . It is possible that through these direct projections, DPAG might excite the RVLM [61, 62] . On the other hand, the effect observed in the more recent experiments is much more prominent (~50%) and independent of sympathoexcitation, which occurs in response to RVLM stimulation [60, 64] . 
Neurogenic neuroprotection
The cognizance of this entity was demonstrated after extensive studies involving stimulation of FN and its consequent modification of CBF dynamics [26, 27, 33, 35, 70, 71] . Previous reports have demonstrated the ability of FNS to induce changes in arterial pressure at rest and in reflex control [26] [27] [28] 70] . Furthermore, there is a global rise of CBF during the FNS, an event that is not accompanied by an increase in the CGU, thus suggesting an absence of functional activation [29, 35] . The first hypothesis was the improvement of blood circulation through collateral arteries in the ischemic penumbra, without associated increase in local functional demand, leading to beneficial action on the vascular ischemic lesion [22] . Although CBF is higher in non-ischemic areas bilaterally, the FNS does not raise CBF in the penumbra area of ischemic infarctions [29] . Consequently, a different mechanism to that linked to CBF variation may be responsible for the neuroprotection phenomenon.
In order to establish the physiological role of neurogenic neuroprotection, some authors have sought to link CBF to cerebral metabolism [29, 35] . The penumbra area presents lower CBF with regard to its cellular metabolism [10, 11, 16, 72] , creating a "misery perfusion"
as described by Baron et al. [72] in 1981.
Conceptually, reduced cellular metabolism in damaged areas could restore the balance needed for cellular viability and explain the mechanism of neurogenic neuroprotection.
Notwithstanding, the FNS fails to reduce glucose utilization in penumbra areas, yet raises it in non-ischemic zones [31, 35, 73] .
The current evidence indicates that neuroprotection triggered by FNS is independent from CBF changes or cellular energetic consumption at the ischemic penumbra [29] . Moreover, several experimental
studies have failed to demonstrate the relationship between neuroprotection and blood pressure variations, hematocrit levels, body temperature and blood gas concentration [43] . However, electrical stimulation of FN does create a specific sympathetic-excitatory effect along with increased arterial blood pressure and cerebral blood flow, tachycardia and activation of predatory behaviors [26, 70] . These neurovegetative effects are not associated with a rise in metabolism [27, 28, 35, 43, 71, 74] . individual and (B) averaged (n = 25 sweeps) bursts recorded at slow sweep-speeds followed by single wave of vasodilation. Note that after averaging, the afterpotential of individual bursts disappears, while only the initial potential remains. With permission from ref. [31] .
Intrinsic regulation of brain inflammatory responses
It has long been recognized that the threshold for inflammation to occur in brain is higher than in other tissues [81] . Some authors however, have suggested that perturbation or dysfunction of certain brain areas could be a contributory factor to the initiation, progression, or lack of resolution of inflammatory responses [82] [83] [84] [85] . Ischemia triggers an inflammatory process in which capillaries, the blood-brain barrier, play a specific role. Also, ischemia induces the production of several pro-inflammatory cytokines, such as IL-β [12, 85, 86] , which may be involved in the expression of isoform-2 of nitric oxide synthase (iNOS or NOS2) [87] [88] [89] and of the adhesion molecule ICAM-1 [90, 91] in local capillaries. The blockade of expression of these components seems to be able to reduce the volume of ischemic infarction [34, 91, 92] .
Therefore, these mechanisms have been explored in order to understand the effect of FNS at a molecular level. 
Apoptosis
The penumbra area has a partially preserved blood supply and is hypermetabolic, which evokes sublethal damage ultimately promoting a delayed apoptotic cell death [93] [94] [95] . Apoptosis is a cell-intrinsic process that is essential for animal development and tissue homeostasis [96] . As the tissue salvaged by FNS after focal ischemic insult follows the contours of the presumed ischemic penumbra, the hypothesis that FN not only suppresses inflammatory reactions [84, 85] but also attenuates apoptotic processes gains merit.
One evolutionarily conserved component in the apoptotic pathway is the involvement [42] . The salvaging effect of FN stimulation was long-lasting and reduced the volume of infarctions 72 h or 10 days later by 58 and 26%, respectively, in Fisher rats [42] . As the effect appears to be global in the brain and given that FN possesses relatively short projections, other relays must be involved in this network.
of the members of the caspase family [97] . [114] and releases mitochondrial proteins [115] . 
Perspectives
The experimental design of the reports cited above adopted the stimulation-followed-by- 
Ischemic events due to vasospasm
Alterations in CBF and metabolism after subarachnoid hemorrhage (SAH) are well known and have been extensively described [3] .
Cerebral vasospasm remains one of the most serious complications after SAH [7, 116, 117] . This is the classic cause of delayed neurological deterioration after aneurysmal subarachnoid hemorrhage that leads to cerebral ischemia and infarction with poor outcomes, and occasionally to death [117] . Cerebral vasospasm consistently fails to respond to treatment, emphasizing the need for further research into the underlying mechanisms of SAH-induced cerebrovascular dysfunction. Over the past decades, several pharmacological approaches have been investigated for the prevention of cerebral vasospasm [3, 118, 119] . Despite advances in the understanding of the pathophysiological nuances of cerebral vasospasm, it has been correlated with a 1.5-to threefold increase in death within the first 2 weeks of the ictal event [119] . Unfortunately, no efficacious treatment is available for this critical patient group [6] [7] [8] 118] .
Classically, vasospasm follows a typical time course, in that its onset usually occurs within 1 week of the hemorrhage, reaches maximum severity between days 7 and 14 post-SAH, and usually dissipates after 14 to 28 days [3, [117] [118] [119] [120] .
The most consistent predictor of vasospasm has been the extent of SAH seen on post-ictal computed tomography (CT) scan [121] [122] [123] . with epidural electrodes has been used to treat chronic pain syndrome and peripheral vascular disease [125] [126] [127] . In addition to its effects on the peripheral vasculature, cervical SCS seems to have a similar effect on the cerebral vasculature. Since the first report by Hosobuchi in 1985 [128] , the ability of SCS to augment CBF has been demonstrated in several clinical and experimental studies. [129] [130] [131] [132] [133] [134] [135] . A number of clinical reports in which authors describe the use of SCS to treat patients with cerebral ischemia have been published [135] [136] [137] .
However, despite the promise of clinical benefit of SCS in the treatment of cerebral ischemia, the effective use of SCS is hampered by a lack of understanding of its mechanism(s) of action.
Evidence from studies of the peripheral vasculature suggests that SCS produces a reversible functional sympathectomy [32, [138] [139] [140] . Modulation of the superior cervical ganglion at a cervical-thoracic transitional level, suppressing efferent signals from their origin to the sympathetic chain may be one explanation.
Further support for such a pathway stems from the finding that concurrent stimulation of the cervical sympathetic chain overcomes the CBF response to SCS [134] . However, although the sympathetic system may play an important role in the pathogenesis of vasospasms Results of a study by Patel et al. [142] demonstrated that surgical interruption of cervical sympathetic outflow has no effect on However, unlike conditioned central neurogenic protection, activation of neurons of the RVLM appears to be less cytoprotective [29] .
Cervical SCS likely has a limited effect only on the RVLM, and does not reflect the true potential of this neuronal circuitry for patients experiencing ischemic suffering due to vasospasm. Deep stimulation of the FN seems to be the best target in order to promote a dual effect on the brain parenchyma: vasodilation and neuroprotection.
Experimental investigations on neurogenic neuroprotection demonstrated a maximum effect, regarding the counteraction of neuronal death, provided the electrical stimulation had occurred 3 days before the middle cerebral artery occlusion in rats [20, 21] . Knowing that ischemic events due to vasospasm occur at 
Malignant cerebral infarctions
Nevertheless, as outlined earlier, there are times when we cannot predict events even in the near future. Malignant middle cerebral artery infarction is a large hemispheric infarction with poor outcome attributable to the ischemic inflammation/edema that causes an early rise in intracranial pressure and subsequent brain herniation and death [1, 9, 11, 12, 146] .
No clinical therapy has proven effective in preventing neuronal death in the penumbra area thereby improving patient outcome [2, 5] .
Surgical decompression techniques have been
proposed to relieve high intracranial pressure, but this represents only a critical intervention in an inexorable process [146] .
The only method currently used to prevent this outcome is the unblocking of the compromised vessel. However, although recombinant tissue-type plasminogen activator (rt-PA) has been approved for acute ischemic stroke, less than 5% of qualifying patients actually receive rt-PA [147, 148] . 
Conclusion
In conclusion, it is hard to conceive a brain protective intrinsic circuit that is activated to render brain less susceptible to traumatic or ischemic events. More likely however, is that the findings of these experimental studies are the result of neuronal circuit hyperactivation. 
